Who Created the Highest Margins Among Czech Pharmaceutical Companies in 2017?

Top Companies by EBITDA Margin (%)
Pharmaceutical | Czech Republic | February 23, 2019
$1.99
Excel Sheet

Based on a comparison of 9 firms among Czech Pharmaceutical Companies, Amgen Czech Republic generated the highest EBIIDA Margin in 2017 followed by Pfizer Czech Republic and Merck Czech Republic.

Amgen Czech Republic made EBITDA of CZK 49.0 mil, which translates into EBITDA margin of 11.8%. Historically, the firm’s margin reached an all time high of 13.8% in 2011 and an all time low of 6.20% in 2016. The average EBITDA margin in the last five years amounted to 8.59%.

Comparing Amgen Czech Republic with its closest peers, Pfizer Czech Republic generated EBITDA of CZK 156 mil with a EBITDA margin of 4.36% in 2017, Merck Czech Republic grossed CZK 72.8 mil (EBITDA margin of 4.00%) and Bayer Czech Republic announced a profit of CZK 158 mil translating into a margin of 3.77%.

You can see all the companies ebitda margin data on the EBITDA Margin indicator page or you can download a special statistical dossier on the Czech Pharmaceutical Companies in the reports section.

EBITDA Margin Unit 2010 2011 2012 2013 2014 2015 2016 2017
Roche Czech Republic % 4.14% 4.20% 6.66% 6.07% 3.84% ...
Merck Czech Republic % 4.14% 4.77% 2.85% 2.98% 5.18%
Amgen Czech Republic % 13.8% 8.95% 8.79% 8.55% 7.66%
Pfizer Czech Republic % 4.64% 2.13% 3.20% 3.48% 3.54%
Bayer Czech Republic % 5.01% 3.46% 3.94% 3.53% 3.93%
GlaxoSmithKline Czech Republic % 5.33% 4.08% 3.34% 2.87% 3.17%
Sanofi-Aventis Czech Republic % 1.29% 1.12% 1.51% 0.278% 1.43%
Novartis Czech Republic % 1.56% 1.78% 1.77% 2.41% 2.42%
Servier Czech Republic % ... ... 5.76% 5.82% 4.72% 3.61%
AVERAGE % 3.94% 4.99% 4.03% 4.21% 3.88% 3.87% 3.96% 3.96%